Search
for
Sort by
Research 481–510 of 1000+
- Acute urinary retention: risks and management.
- Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Practical Geriatrics: Men's Sexual Health After Midlife
- Comparison Between Two Different Hamster Models used for the Determination of Testosterone and Finasteride Activity
- Homology Modeling of 5-alpha-Reductase 2 Using Available Experimental Data
- Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem)
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- Paxillin regulates androgen receptor expression associated with granulosa cell focal adhesions
- Signal Detection of Depression and Suicidality Associated with Finasteride and Dutasteride: Updated Pharmacovigilance Evidence and Recommendations for Comprehensive Psychiatric Assessment
- Evaluation of residual symptoms and anxiety among patients on therapy for benign prostatic hyperplasia at a Nigerian tertiary healthcare facility
- Trapa bispinosa Roxb. Pericarp Extract Exerts 5α-Reductase Inhibitory Activity in Castrated Benign Prostatic Hyperplasia Model Mice
- Synthesis of novel andostane-N-cyclohexyl-17-carboxamides, and their effect on the 5α-reductase isoform 2, the androgen receptor, and androgen-dependent glands
- 전립선 비대유도 쥐의 전립선 조직에서 울금 급여에 따른 염증인자의 변화
- Notes from the Editor Emeritus: Finasteride: the downtrodden hero of hair transplantation emerges once again
- Synthesis, Characterization and Evaluation of 5α, 6β-Dihalo Androsterone Derivatives as 5α-Reductase Inhibitors
- One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Role of ACE2 polymorphism in COVID-19: impact of age
- Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness
- Autotaxin–lysophosphatidic acid– LPA <sub>3</sub> signaling at the embryo‐epithelial boundary controls decidualization pathways
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Guidelines on the use of finasteride in androgenetic alopecia
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity
- Sox21 Regulates Anapc10 Expression and Determines the Fate of Ectodermal Organ
- Corn silk extract improves benign prostatic hyperplasia in experimental rat model
- Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians
- The immune response to COVID‐19: Does sex matter?
- Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature